CD274 and neoplasm: At this stage, we do not know whether the negative impact of benzodiazepines use would be independent of other established modulatory effects of the pembrolizumab response such as performance status, tumor burden, PD-L1 expression, tumor mutational burden, or gene expression signatures within the tumor49 (which all are not available in the SNDS database).